News

Filter

Current filters:

Eli LillyReproductive

FDA approves Lilly’s Cialis to treat benign prostatic hyperplasia

07-10-2011

The US Food and Drug Administration yesterday approved drug major Eli Lilly’s (NYSE: LLY) Cialis…

CialisEli LillyNorth AmericaPharmaceuticalRegulationReproductive

Chiesi, Eli Lilly and Bayer named for breaches of the ABPI Code of Practice

31-05-2011

The UK subsidiaries of Italy’s Chiesi, US drug major Eli Lilly (NYSE: LLY) and Germany’s Bayer…

BayerChiesi FarmaceuticiEli LillyEuropeLevitraNeurologicalPharmaceuticalRegulationReproductiveYasmin

US FDA approves Axiron, first testosterone replacement from Eli Lilly and Acrux

25-11-2010

US drug major Eli Lilly (NYSE: LLY) and Australian partner Acrux (ASX: ACR) have received US Food and…

AcruxAxironEli LillyNorth AmericaPharmaceuticalRegulationReproductive

Market development key for testosterone replacement therapy, set to be a $1.4 billion market in 2019

17-11-2010

Despite growing at a compound annual growth rate of more than 24% over the last five years, the testosterone…

AxironEli LillyMarkets & MarketingPharmaceuticalReproductive

COMPANY SPOTLIGHT

Menarini

Back to top